Fulvestrant Impurity 7

Fulvestrant Impurity 7 Suppliers list
Company Name: Standardpharm Co. Ltd.
Tel: 86-714-3992388
Email: overseasales1@yongstandards.com
Products Intro: Product Name:Fulvestrant Impurity 7
Purity:0.99 Package:10mg;25mg;50mg;100mg
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Products Intro: Product Name:Fulvestrant Impurity 7
CAS:1673530-91-0
Remarks:Fulvestrant Impurity 7 is an impurity of Fulvestrant, which is a drug for breast cancer.
Company Name: Jinan blalong chemical co. LTD  
Tel: 2710913286@.com
Email: 1513643261@qq.com
Products Intro: Product Name:FulvestrantImpurity7
CAS:1673530-91-0
Purity:99% HPLC Package:50G;10G;1G;500MG;100MG
Company Name: Shenzhen ruikai de biotechnology co., ltd.  
Tel: 0755-61348847 17820674378
Email: 2682116078@qq.com
Products Intro: Product Name:Fulvestrant Impurity 7
CAS:1673530-91-0
Purity:98%HPLC Package:10mg;25mg;50mg;100mg
Company Name: Hubei Ruinuo Pharmaceutical Technology Co., Ltd  
Tel: 13165688766
Email: 3008058303@qq.com
Products Intro: Product Name:Fulvestrant Impurity 8
CAS:1673530-91-0
Purity:99% HPLC Package:10mg;25mg;50mg;100mg等多种规格
Fulvestrant Impurity 7 Basic information
Product Name:Fulvestrant Impurity 7
Synonyms:Fulvestrant Impurity 7;Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]-, (17β)-;7a-[9-[(4,4,5,5,5-pentafluoropentyl)thio]nonyl]- estradiol(Fulvestrant N-1)
CAS:1673530-91-0
MF:C32H47F5O2S
MW:590.78
EINECS:
Product Categories:
Mol File:1673530-91-0.mol
Fulvestrant Impurity 7 Structure
Fulvestrant Impurity 7 Chemical Properties
Boiling point 622.1±55.0 °C(Predicted)
density 1.159±0.06 g/cm3(Predicted)
pka10.27±0.70(Predicted)
Safety Information
MSDS Information
Fulvestrant Impurity 7 Usage And Synthesis
Fulvestrant Impurity 7 Preparation Products And Raw materials
Tag:Fulvestrant Impurity 7(1673530-91-0) Related Product Information
(Fulvestrant EP Impurity B) Fulvestrant EP Impurity E Fulvestrant Impurity 4 Fulvestrant Impurity 3 (7R,8R,9S,10R,13S,14S,17S)-7-(9-hydroxynonyl)-13-methyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate